KLA Corp <KLAC.O>: UBS cuts target price to $215 from $240
KLAC•Related News
Altisource Portfolio Solutions Chair, CEO William Shepro acquires common shares worth $20,720
ASPS•
Teva Pharm seeking details on Trump drug tariffs plan, CEO says
TEVA•
Nasdaq Trade Halt Continues <PLTS.O> Reason Not Available at 10:41 AM
PLTS•
Amphenol Q2 FY26 GAAP diluted EPS rises 59% to $1.37; sales climb 55% to $8.8 billion
APH•
Karooooo CEO and Executive Chairman Calisto Isaias Jose sells common shares worth $3.07 million
KARO•